vendredi 9 décembre 2016

Onco Actu du 9 décembre 2016

3.1 Tabac

Australia’s plain cigarette packs get more support than expected [Reuters]

3.1.1 Tabac - e-cigs

E-cigarettes are unsafe and ‘major public health concern’ for young people, warns US surgeon general [The Telegraph]

Know the Risks - E-cigarettes & Young People [Surgeon General]

What Are the Risks for Teens Who Use E-Cigarettes? [The Atlantic]

3.8 Prévention - Alimentation

Can cutting out chocolate really hold cancer at bay? [Cancer Research UK]

4. Dépistage, diagnostic et pronostic

Stem cell biomarker predicts leukemia patients' response to chemo [FierceBiotech]

Craig Venter Used Own Posh Health Clinic To Diagnose His Cancer [Xconomy]

5.12 Immunothérapies

Personalised cancer vaccine may hold leukaemia at bay for longer [Cancer Research UK]

Too many stories ignore or underreport the harms of cancer immunotherapies. Here’s what the public needs to know. [HealthNewsReview]

5.12.2 Immunothérapies - CAR-T

Immuno-oncology startup TCR2 promises to improve on CAR-T [FierceBiotech]

5.2 Pharma

Celgene Pins Future on Decoding Successful Cancer Treatment [Bloomberg]

5.2.1 Pharma - Partenariats

Cancer Research Technology pioneer fund announces investment in blood cancer drugs [Cancer Research UK]

5.3.4 Traitements - AMM (FDA, EMA)

European Commission Grants Conditional Marketing Approval for AbbVie's VENCLYXTO™ (venetoclax) Monotherapy for Appropriate Patients with Difficult-To-Treat Chronic Lymphocytic Leukaemia [AbbVie]

5.5 ASCO

2017 Gastrointestinal Cancers Symposium Press Program to Highlight New Treatment Insights and Strategies [ASCO]

5.7.2 SABCS-divers

New drug combination shows early promise for some breast cancer patients [Cancer Research UK]


Adding an Aromatase Inhibitor to Presurgery Treatment for HR-positive, HER2-positive Breast Cancer Provided No Additional Benefit [AACR]

Phase II Trial of Presurgery Abemaciclib Treatment for Early-stage HR-positive, HER2-negative Breast Cancer Met Primary Endpoint [AACR]

BELLE-3 Trial Meets Primary Endpoint of Progression-free Survival in Breast Cancer Patients [AACR]

Adding Ibandronate to Hormone Therapy did Not Improve Outcomes For Postmenopausal Breast Cancer Patients [AACR]

Radiation Therapy May Increase Complications in Breast Cancer Patients Receiving Implants [AACR]

6. Lutte contre les cancers

The Health Research Alliance Partners with ÜberResearch to Launch New Database [Digital Science]

6.1 Observation

More foreign holidays will mean more skin cancer, scientists predict [The Guardian]

6.10.1 Politiques (USA)

Destroying the FDA to save it? No, more like just destroying it. [Respectful Insolence]

Why Donald Trump's Putative FDA Pick Could Scare Pharma [Forbes]

Congressional Memo: Cures Act Gains Bipartisan Support That Eluded Obama Health Law [NY Times]

6.6 Publications

Controversial impact factor gets a heavyweight rival [Nature]